A65 (P462)Retinal microvascular biomarkers are associated with incidence and progression of diabetic retinopathy in Type 2 diabetes: A GoDARTS‐VAMPIRE studyTM LI1, C Palmer1, E Pearson2, T MacGillivray3, E Trucco4, L Ballerini5, R Wang4, D Relan4, GJ McKay6 and A Doney71Ninewells Hospital and Medical School, University of Dundee, Dundee, UK, 2Division of Molecular & Clinical Medicine, Ninewells Hospital and Medical School, Dundee, UK, 3Biomedical Research Institute, Ninewells Hospital and Medical School, Dundee, UK, 4Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK, 5Computer Vision and Image Processing Group, University of Dundee, Dundee, UK, 6Centre for Public Health, Queen's University Belfast, Belfast, UK, 7Medicines Monitoring Unit, Ninewells Hospital and Medical School, Dundee, UKAim: Early risk prediction of diabetic retinopathy (DR) would significantly enhance clinical prevention strategies. We aimed to determine the value of retinal vascular parameters (RVPs) as biomarkers for incidence and progression of DR from 4,461 patients with Type 2 diabetes.Method: We used VAMPIRE 3.1 software to measure central retinal artery and vein equivalent, their ratio (artery and vein ratio, AVR), arteriolar and venular tortuosity (TortA, TortV), and fractal dimension (Da, Dv) in diabetes retinal screening photographs (DRS) in GoDARTS. Cox's proportional hazards were used to model the impact
Diabetic Medicine – Wiley
Published: Jan 1, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera